Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
Top Cited Papers
Open Access
- 16 March 2006
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 19 (4) , 514-523
- https://doi.org/10.1038/modpathol.3800534
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Detection of Hypermethylated Genes in Women with and Without Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 2005
- Identifying target populations for screening or not screening using logic regressionStatistics in Medicine, 2004
- Identifying interacting SNPs using Monte Carlo logic regressionGenetic Epidemiology, 2004
- Regulatory motif finding by logic regressionBioinformatics, 2004
- Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markersLaboratory Investigation, 2004
- Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 CasesLaboratory Investigation, 2002
- Value of p63 and Cytokeratin 5/6 as Immunohistochemical Markers for the Differential Diagnosis of Poorly Differentiated and Undifferentiated CarcinomasAmerican Journal of Clinical Pathology, 2001
- An Optimized Battery of Eight Antibodies That Can Distinguish Most Cases of Epithelial Mesothelioma From AdenocarcinomaAmerican Journal of Clinical Pathology, 2000
- Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the PleuraLaboratory Investigation, 2000
- In Search of a Positive lmmunohistochemical Marker for MesotheliomaAdvances in Anatomic Pathology, 1998